Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 4 | Journal of Biomedical Science

Fig. 4

From: HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC

Fig. 4

The tumor characteristics and prognosis of patients with HBV-TERT(+) HCCs tend to be mitigated by HCV superinfection. A, B Comparison of RFS (A) and OS (B) between int(+) HBV-HCCs (green line), int(–) HCV-HCCs (magenta line), int(+) HBCV-HCCs (orange line), and int(–) HBCV-HCCs (gray line) patients by Kaplan‒Meier analysis. C, D Comparison of RFS (C) and OS (D) of HBV-TERT (+) HBCV-HCCs (red line) and HBV-TERT (+) HBV-HCCs (blue line) patients by Kaplan‒Meier analysis. E, F GSEA plots of gene sets related to (E) CTNNB1 downstream signaling and (F) cell stemness between HBV-TERT(+) HBCV-HCCs (n = 3) and HBV-TERT(+) HBV-HCCs (N = 15).

Back to article page

Journal of Biomedical Science

ISSN: 1423-0127